Samy Suissa
Professor Samy Suissa is a Distinguished James McGill Professor in the Departments of Epidemiology and Biostatistics, and of Medicine at McGill University, and Director of the Centre of Clinical Epidemiology, Jewish General Hospital, in Montreal, Canada. He founded the McGill Pharmacoepidemiology Research Unit and leads the Canadian Network for Observational Drug Effect Studies (CNODES). He has conducted several pharmacoepidemiological studies on the risks and benefits of medications for the treatment of many chronic diseases, including asthma, COPD, rheumatic diseases and diabetes. He also works on the development of methods to improve the conduct of these studies, as well as the identification and dissemination of time-related biases to avoid methodological flaws from such studies. He has authored over 500 papers and is on the editorial boards of several journals. Professor Suissa is a fellow of the Royal Society of Canada and the Canadian Academy of Health Sciences, received the Distinguished Investigator award from the Canadian Institutes of Health Research and the FC Donders Professorship Award from Universiteit Utrecht, Netherlands.
听
Dr. Suissa鈥檚 research is in the area of pharmacoepidemiology which involves studying the risks and benefits of medications in the population at large and in the real world setting of clinical practice. He specializes in the exploitation of existing computerized health databases to rapidly evaluate these effects. He has developed new methods of data analysis and study design that allow more rapid and accurate assessments of drug effects. He has conducted pharmacoepidemiological studies of several medications used for the treatment of chronic diseases, including asthma and COPD, cardiovascular and rheumatic diseases, and women鈥檚 health issues. He has lectured extensively throughout the world, and is the author of over 500 peer-reviewed research papers published in scientific journals. He leads the Canadian Network for Observational Drug Effect Studies (CNODES), a team of over 60 scientists across the country collaborating to evaluate the effects of medications used by Canadians.
Keywords:听Pharmacoepidemiology COPD Drug Safety Observational Studies